RAJEEV KULKARNI (MD) – Hematology & Oncology Physician, NPI 1598825085
Hematology & Oncology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
599 HEMATOLOGY/ONCOLOGY in OH
Provider Addresses for RAJEEV KULKARNI (MD)
3130 N DIXIE HWY STE 107
TROY, OH 453731337
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
St. Joseph Orphanage – Dayton Office, 6680, Poe Avenue, North Dayton, Vandalia, Montgomery County, Ohio, 45414, United States
SUITE 200
DAYTON, OH 454142854
Phone: (937) 280-8400
Fax: (937) 280-8373
Type: Mailing
6680 POE AVE STE 200
DAYTON, OH 454142855
Phone: (937) 280-8400
Fax: (937) 280-8373
Type: Mailing
855 W MARKET ST
TROY, OH 453733837
Phone: (937) 293-1622
Fax: (937) 245-6308
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 250 Open Payments records for all available years, with a total value of $4,941.
Total Amount is formed as General ($4,941) + Research ($0) + Ownership ($0) = $4,941.
Last reported payment date: 2024-12-20 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($368).
Total Amount
$4,941
General + Research + Ownership
Payments
250
Total payment records
General Amount
$4,941
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-20
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $368 |
| PFIZER INC. | $358 |
| AstraZeneca Pharmaceuticals LP | $302 |
| ABBVIE INC. | $238 |
| Pharmacyclics LLC, an AbbVie Company | $232 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2004-02-19
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20040219000542 | I | Hematology/Oncology | OH | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J1756 | Injection, iron sucrose, 1 mg | 56,000 | 47 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 28,400 | 15 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 16,200 | 18 | $0 |
| J0897 | Injection, denosumab, 1 mg | 7,980 | 14 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,808 | 26 | $0 |
Insurance plans in this area (ZIP 45373)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | OH | 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 51 | 43 |
| HEMATOLOGY/ONCOLOGY | OH | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 314 | 62 |
| HEMATOLOGY/ONCOLOGY | OH | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 309 | 58 |
Group practice members
- 1
- 2
- 3
- 4
- 5
| Name | Specialty | State |
|---|---|---|
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| - | OH | |
| Radiation Oncology | OH | |
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| U R O L O G Y | OH | |
| H E M A T O L O G Y/ O N C O L O G Y | OH | |
| - | OH | |
| Nurse Practitioner | OH | |
| - | OH | |
| U R O L O G Y | OH |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.